Cargando…

Discovery and Validation of Lmj_04_BRCT Domain, a Novel Therapeutic Target: Identification of Candidate Drugs for Leishmaniasis

Since many of the currently available antileishmanial treatments exhibit toxicity, low effectiveness, and resistance, search and validation of new therapeutic targets allowing the development of innovative drugs have become a worldwide priority. This work presents a structure-based drug discovery st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peña-Guerrero, José, Fernández-Rubio, Celia, Burguete-Mikeo, Aroia, El-Dirany, Rima, García-Sosa, Alfonso T., Nguewa, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508789/ https://www.ncbi.nlm.nih.gov/pubmed/34638841 http://dx.doi.org/10.3390/ijms221910493

Ejemplares similares

Characterization of Leishmania Parasites Isolated from Naturally Infected Mammals
por: Burguete-Mikeo, Aroia, et al.
Publicado: (2023)

The BRCT Domain from the Homologue of the Oncogene PES1 in Leishmania major (LmjPES) Promotes Malignancy and Drug Resistance in Mammalian Cells
por: Larrea, Esther, et al.
Publicado: (2022)

BRCT Domains: Structure, Functions, and Implications in Disease—New Therapeutic Targets for Innovative Drug Discovery against Infections
por: Peña-Guerrero, José, et al.
Publicado: (2023)

LmjF.22.0810 from Leishmania major Modulates the Th2-Type Immune Response and Is Involved in Leishmaniasis Outcome
por: Vacas, Andrés, et al.
Publicado: (2020)

Leishmaniasis en Navarra (1976-2018): actualización
por: Burguete-Mikeo, A., et al.
Publicado: (2022)

The Novel Serine/Threonine Protein Kinase LmjF.22.0810 from Leishmania major May Be Involved in the Resistance to Drugs such as Paromomycin
por: Vacas, Andrés, et al.
Publicado: (2019)

Repurposing the Antibacterial Agents Peptide 19-4LF and Peptide 19-2.5 for Treatment of Cutaneous Leishmaniasis
por: El-Dirany, Rima, et al.
Publicado: (2022)

Identification of the Leishmania major Proteins LmjF07.0430, LmjF07.0440, and LmjF27.2440 as Components of Fatty Acid Synthase II
por: Gurvitz, Aner
Publicado: (2009)

Structural studies of the PARP-1 BRCT domain
por: Loeffler, Paul A, et al.
Publicado: (2011)

Activity of Anti-Microbial Peptides (AMPs) against Leishmania and Other Parasites: An Overview
por: El-Dirany, Rima, et al.
Publicado: (2021)

The BRCT Domain of PARP-1 Is Required for Immunoglobulin Gene Conversion
por: Paddock, Marcia N., et al.
Publicado: (2010)

Functional Evolution of BRCT Domains from Binding DNA to Protein
por: Sheng, Zi-Zhang, et al.
Publicado: (2011)

Structure of BRCA1-BRCT/Abraxas Complex Reveals Phosphorylation-Dependent BRCT Dimerization at DNA Damage Sites
por: Wu, Qian, et al.
Publicado: (2016)

Impact of BRCA1 BRCT Domain Missense Substitutions on Phosphopeptide Recognition
por: Coquelle, Nicolas, et al.
Publicado: (2011)

Correction: The BRCT Domain of PARP-1 Is Required for Immunoglobulin Gene Conversion
por: Paddock, Marcia N., et al.
Publicado: (2018)

Structural insights into Rad18 targeting by the SLF1 BRCT domains
por: Huang, Wei, et al.
Publicado: (2023)

The BRCT domain of mammalian Rev1 is involved in regulating DNA translesion synthesis
por: Jansen, Jacob G., et al.
Publicado: (2005)

The FHA and BRCT domains recognize ADP-ribosylation during DNA damage response
por: Li, Mo, et al.
Publicado: (2013)

Potential therapeutic targets shared between leishmaniasis and cancer
por: Rashidi, Sajad, et al.
Publicado: (2021)

The BRCT domain of mammalian Pes1 is crucial for nucleolar localization and rRNA processing
por: Hölzel, Michael, et al.
Publicado: (2007)

Effects on human transcriptome of mutated BRCA1 BRCT domain: A microarray study
por: Iofrida, Caterina, et al.
Publicado: (2012)

Phosphopeptide interactions with BRCA1 BRCT domains: More than just a motif
por: Wu, Qian, et al.
Publicado: (2015)

Phosphopeptide interactions of the Nbs1 N-terminal FHA-BRCT1/2 domains
por: Kim, Kyungmin, et al.
Publicado: (2021)

The N-terminal BRCT domain determines MCPH1 function in brain development and fertility
por: Liu, Xiaoqian, et al.
Publicado: (2021)

Role of BRCT motif containing proteins in Chk1 activation
por: Beniston, RG, et al.
Publicado: (2006)

An atypical BRCT–BRCT interaction with the XRCC1 scaffold protein compacts human DNA Ligase IIIα within a flexible DNA repair complex
por: Hammel, Michal, et al.
Publicado: (2020)

Vertebrate DNA damage tolerance requires the C-terminus but not BRCT or transferase domains of REV1
por: Ross, Anna-Laura, et al.
Publicado: (2005)

Structural basis to stabilize the domain motion of BARD1-ARD BRCT by CstF50
por: Choudhary, Rajan Kumar, et al.
Publicado: (2017)

Biophysical evaluation to categorize pathogenicity of cancer-predisposing mutations identified in the BARD1 BRCT domain
por: Choudhary, Rajan Kumar, et al.
Publicado: (2018)

Mutations in the BRCT binding site of BRCA1 result in hyper-recombination
por: Dever, Seth M., et al.
Publicado: (2011)

In Leishmania major, the Homolog of the Oncogene PES1 May Play a Critical Role in Parasite Infectivity
por: Algarabel, Miriam, et al.
Publicado: (2021)

Phospho-epitope binding by the BRCT domains of hPTIP controls multiple aspects of the cellular response to DNA damage
por: Munoz, Ivan M., et al.
Publicado: (2007)

Phospho-epitope binding by the BRCT domains of hPTIP controls multiple aspects of the cellular response to DNA damage
por: Munoz, Ivan M., et al.
Publicado: (2017)

Targeting Phosphopeptide Recognition by the Human BRCA1 Tandem BRCT Domain to Interrupt BRCA1-Dependent Signaling
por: Periasamy, Jayaprakash, et al.
Publicado: (2018)

Analysis of BRCT5 domain-containing proteins reveals a new component of DNA damage repair in Arabidopsis
por: Vladejić, Jovanka, et al.
Publicado: (2022)

Classification of VUS and unclassified variants in BRCA1 BRCT repeats by molecular dynamics simulation
por: Sinha, Siddharth, et al.
Publicado: (2020)

BRCT domains of the DNA damage checkpoint proteins TOPBP1/Rad4 display distinct specificities for phosphopeptide ligands
por: Day, Matthew, et al.
Publicado: (2018)

p38 MAPK signaling and phosphorylations in the BRCT1 domain regulate XRCC1 recruitment to sites of DNA damage
por: de Sousa, Mirta Mittelstedt Leal, et al.
Publicado: (2017)

Trans-activation-based risk assessment of BRCA1 BRCT variants with unknown clinical significance
por: Langerud, Jonas, et al.
Publicado: (2018)

Editor's note to ‘phospho-epitope binding by the BRCT domains of hPTIP controls multiple aspects of the cellular response to DNA damage’
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_42ol4e79te2n504pgjjplbt2o3